Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder
一项针对自闭症谱系障碍患者的随机对照试验，研究了益生菌制剂SB-121的Ib期临床试验结果。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-30909-0
Schmitt, Lauren M; Smith, Elizabeth G; Pedapati, Ernest V; Horn, Paul S; Will, Meredith; Lamy, Martine; Barber, Lillian; Trebley, Joe; Meyer, Kevin; Heiman, Mark; West, Korbin H J; Hughes, Phoevos; Ahuja, Sanjeev; Erickson, Craig A
